Background We report the first case of canine Salmonella meningoencephalomyelitis and second case of canine Salmonella bacteriuria, as well as the first reported case of Salmonella enterica subspecies houtenae in a dog. Case presentation Immunosuppressive treatment in a dog for a relapse of steroid-responsive meningitis and arteritis (SRMA) allowed for the opportunistic establishment of a bacteremia with Salmonella enterica subsp. houtenae, ultimately causing meningoencephalomyelitis and subclinical bacteriuria. The bacterial infections were treated with a four-month course of amoxicillin; clinical treatment success was determined by serial negative urine cultures and lack of clinical signs correlated to the meningoencephalomyelitis. Conclusions Both the bacteriuria and meningoencephalomyelitis represented opportunistic infections in a dog immunosuppressed for SRMA. The clinical course of this infectious meningoencephalitis emphasizes the importance of differentiating relapse of initial disease from opportunistic infection occurring in a compromised central nervous system. The novel Salmonella species identified in this case acts as a reminder that infectious disease diagnostics should not be curbed by anecdotal prediction of routine pathogenic suspects.
Sporadic glioma occurs in companion dogs at frequencies comparable to humans, despite differences in environmental exposures and age at time of diagnosis. Despite advances in molecular and phenotypic characterization of adult gliomas, accurate prognostication and curative treatment modalities are often limited by lack of animal translational models that can faithfully recapitulate underlying oncogenic processes and treatment response to newer therapies. Studying canine glioma at molecular level has several merits: First, it has a distinct advantage over genetically modified animal models to study natural course of glioma in dogs. Second, breed-specific elevated cancer risk, e.g., short-nosed breeds have higher risk for gliomas and smaller effective population size compared to humans potentially allow better characterization driver elements in the evolving canine glioma. Finally, dogs with the natural mammalian immune system have spontaneous occurrence of glioma, making it an ideal model for preclinical immunotherapy testing. Based on these merits, we performed whole genome, exome, transcriptome and methylation (reduced bisulfite) sequencing on 178 canine tumor and germline samples. As in humans, we show frequently occurring mutations and copy number alterations in canine gliomas in p53 pathway, cell cycle pathway (CDK4, CDKN2A), and receptor tyrosine kinases (EGFR, PDGFRA). We identified R132 mutations in the IDH1 gene reflecting a remarkable and species-agnostic but cancer-specific driving effect. Frequent whole chromosome gains were observed of syntenic region of chromosome 13, harboring human glioma oncogenes PDGFRA and MYC, but human glioma specific changes such as 1p/19q co-deletion and whole chromosome 10 loss/whole chromosome 7 gain were absent. We calculate mutational processes and highlight ones related to DNA damage repair and transcriptional strand bias in driving glioma in both species. Based on recent study, we also estimate relative timing of mutations in driver genes and copy number gains in canine glioma and compare those to human glioma in mapping life history of glioma, i.e., are canine glioma more similar to adult or pediatric human glioma cohort? In addition, transcriptional profiling delineated tumor-associated cell fractions from 22 immune cell types. The monocyte gene signature scored highest among canine glioma transcriptomes, in contrast to macrophages/microglia in human disease. Our results suggest similarities between the canine and human glioma microenvironment and we are validating those using canine immunohistochemistry. In bringing together a large canine glioma genomic and transcriptomic sequencing dataset and comparing to human glioma, our study provides unique new insights into glioma etiology and the chronology of glioma-causing somatic alterations. Citation Format: Samirkumar B. Amin, Juan Emmanuel Martinez-Ledesma, Beth Boudreau, Hoon Kim, Kevin C. Johnson, Peter V. Dickinson, Rebecca Packer, Amanda R. Taylor, John H. Rossmeisl, Amy Heimberger, Jonathan Levine, Roel Verhaak. Genomic profiling of canine glioma: Comparative analyses with respect to drivers of human glioma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 1176.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.